Ghent, Belgium

Lennart Zabeau

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 58(Granted Patents)


Location History:

  • Gent, BE (2009)
  • Zwijnaarde, BE (2021 - 2022)
  • Ghent, BE (2007 - 2023)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: **Lennart Zabeau: Innovator and Inventor in Biotherapeutics**

Introduction

Lennart Zabeau is a renowned inventor based in Ghent, Belgium, with a remarkable portfolio consisting of 13 patents. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic agents that target critical pathways in disease treatment.

Latest Patents

Among his latest innovations, Zabeau has developed binding agents targeting PD-1 and PD-L1. These agents hold promise as both diagnostic and therapeutic tools, with implications for treating various diseases. His patent work includes pharmaceutical compositions that incorporate these binding agents to enhance treatment efficacy. Additionally, he has crafted innovative CLEC9A-based chimeric protein complexes, which include an anti-Clec9A targeting moiety. These complexes showcase modified Fc domains and modified human IFNα, further establishing their potential as therapeutic agents and leading to new pharmaceutical compositions that aim to combat diverse diseases.

Career Highlights

Zabeau has shared his expertise with notable companies such as Orionis Biosciences BV and Orionis Biosciences, Inc. His career in these organizations has been marked by collaboration at the forefront of research and development in biomedicine, optimizing the use of innovative binding agents in therapeutic applications.

Collaborations

Throughout his career, Zabeau has collaborated with esteemed colleagues, including Jan Tavernier and Nikolai Kley. Their joint efforts in research and innovation have contributed to the successful development of groundbreaking biotherapeutic solutions that could benefit many patients.

Conclusion

Lennart Zabeau stands out as a prolific inventor whose work in binding agents and chimeric protein complexes continues to advance the field of biotechnology. His patents not only represent individual brilliance but also a commitment to improving therapeutic strategies in healthcare. With each innovation, Zabeau is paving the way for future advancements that may transform disease management and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…